Thyroid hormone treatment aiming at reduced, but not suppressed, serum thyroid-stimulating hormone levels in nontoxic goitre: Effects on bone metabolism amongst premenopausal women

Journal of Internal Medicine

Volumn 243, Issue 2, 1998, Pages 149-154

  Knudsen, N ^a,d   Faber, J ^a,b   Sierbaek Nielsen A ^a   Vadstrup, S ^a   Sorensen H A ^c   Hegedus L ^b  

^a FREDERIKSBERG HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c Center for Health and Society   (Denmark)

^d BISPEBJERG HOSPITAL   (Denmark)

Author keywords

Bone metabolism; Goitre; Thyroid hormones; Ultrasound

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM ION; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; HYDROXYPROLINE; LIOTHYRONINE; OSTEOCALCIN; PARATHYROID HORMONE; PROCOLLAGEN; PYRIDINOLINE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; BONE MASS; BONE METABOLISM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FEMUR NECK; GOITER; HUMAN; LUMBAR SPINE; PREMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; URINE LEVEL;

ADULT; BONE AND BONES; FEMALE; GOITER; HUMANS; MATCHED-PAIR ANALYSIS; MIDDLE AGED; PREMENOPAUSE; PROSPECTIVE STUDIES; THYROTROPIN; THYROXINE; TREATMENT OUTCOME; TRIIODOTHYRONINE;

EID: 0031980501     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1998.00258.x     Document Type: Article

References (17)

1. Perrild H, Hansen JM, Hedgedüs L. et al. Triiodothyronine and thyroxin treatment of diffuse non-toxic goitre evaluated by ultrasonic scanning. Acta Endocrinologica 1982; 100: 382-7.
2. Faber J, Galløe A. Changes in bone mass during prolonged subclinical hyperthyroidism due to thyroxine treatment: a metaanalysis. Eur J Endocrinol 1994; 130: 350-6.
3. Marcocci C, Golia F, Bruno-Bossio G, Vignali E, Pinchera A. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women. J Clin Endrocrinol Metab 1994; 78: 818-23.
4. Fujiyama K, Kiriyama T, Ito M et al. Suppressive doses of thyroxine do not accelerate age-related bone loss in late postmenopausal women. Thyroid 1995; 5: 13-17.
5. Taelman P, Kaufman J, Janssens X, Vandecauter H, Vermeulen A. Reduced forearm bone mineral content and biochemical evidence of increased bone turnover in women with euthyroid goitre treated with thyroid hormone. Clin Endocrinol 1990; 33: 107-17.
6. Faber J, Gam A, Siersbæk-Nielsen K. Improved sensitivity of serum thyrotropin measurements. Studies on serum sex hormone-binding globuline in patients with reduced serum thyrotropin. Acta Endrocrinol 1990; 123: 535-40.
7. Kollerup G, Thamsborg G, Bhatia H, Sørensen OH. Quantitation of urinary hydroxypridinium cross links from collagen by high-performance liquid chromatography. Scand J Clin Lab Invest 1992; 52: 657-62.
8. Kivirikko KT, Laitinen O, Prockop DJ. Modification of a specificassay for hydroxyproline in urine. Anal Biochem 1967; 19: 249-55.
9. Hegedüs L, Perrild H, Poulsen LR et al. The determination of thyroid volume by ultrasound and its relationship to body weight, age and sex in normal subjects. J Clin Endocrinol Metab 1983; 56: 260-3.
10. Pioli G, Pedrazoni M, Palummeri E et al. Longitudinal study of bone loss after thyroidectomy and suppressive thyroxine therapy in premenopausal women. Acta Endocrinol 1992; 126: 238-42.
11. Faber J, Overgaard K, Jarløv A, Christiansen C. Bone metabolism in premenopausal women with nontoxic goitre and reduced serum thyrotropin levels. Thyroidol Clin Exp 1994; 6: 27-32.
12. Faber J, Perrild H, Johansen J. Bone Gla protein and sex hormone-binding globulin in nontoxic goitre: parameters for metabolic status at the tissue level. J Clin Endocrinol Metab 1990; 70: 49-55.
13. Anderson D. Sex-hormone-binding globulin. Clin Endocrinol 1974; 3: 69-96.
14. Mudde A, Reijnders F, Kruseman A. Peripheral bone density in women with untreated multinodular goitre. Clin Endocrinol 1992; 37: 35-9.
15. Mudde A, Houben A, Kruseman A. Bone metabolism during anti-thyroid drug treatment of endogenous subclinical hyperthyroidism. Clin Endocrinol 1994; 41: 421-4.
16. Eriksen E. Normal and pathological remodeling of human trabecular bone: three dimensional reconstruction of the remodeling sequence in normals and in metabolic bone disease. Endocrine Reviews 1986; 7: 379-408.
17. Wenzel K. Thyroid hormone and bone. Thyroid 1995; 5: 508-9.